446 related articles for article (PubMed ID: 19088106)
21. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
22. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.
Matsuzaki S; Darcha C
Hum Reprod; 2014 Aug; 29(8):1677-87. PubMed ID: 24876174
[TBL] [Abstract][Full Text] [Related]
23. Animal models for anti-angiogenic therapy in endometriosis.
Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
[TBL] [Abstract][Full Text] [Related]
24. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis.
Tesone M; Bilotas M; Barañao RI; Meresman G
Gynecol Obstet Invest; 2008; 66 Suppl 1():10-8. PubMed ID: 18936547
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.
Cohen J; Naoura I; Castela M; Von N'Guyen T; Oster M; Fontaine R; Chabbert-Buffet N; Darai E; Aractingi S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():70-7. PubMed ID: 25461356
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis and antiangiogenic therapy in endometriosis.
Becker CM; D'Amato RJ
Microvasc Res; 2007; 74(2-3):121-30. PubMed ID: 17574280
[TBL] [Abstract][Full Text] [Related]
27. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis.
Moggio A; Pittatore G; Cassoni P; Marchino GL; Revelli A; Bussolati B
Fertil Steril; 2012 Dec; 98(6):1521-30.e2. PubMed ID: 22981172
[TBL] [Abstract][Full Text] [Related]
28. Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.
Bilotas M; Meresman G; Stella I; Sueldo C; Barañao RI
Fertil Steril; 2010 May; 93(8):2513-8. PubMed ID: 19819437
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
30. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.
Hull ML; Prentice A; Wang DY; Butt RP; Phillips SC; Smith SK; Charnock-Jones DS
Hum Reprod; 2005 Feb; 20(2):350-8. PubMed ID: 15567877
[TBL] [Abstract][Full Text] [Related]
31. Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo experimental model.
González-Ramos R; Van Langendonckt A; Defrère S; Lousse JC; Mettlen M; Guillet A; Donnez J
Gynecol Obstet Invest; 2008; 65(3):174-86. PubMed ID: 18025832
[TBL] [Abstract][Full Text] [Related]
32. Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.
Canosa S; Moggio A; Brossa A; Pittatore G; Marchino GL; Leoncini S; Benedetto C; Revelli A; Bussolati B
Mol Hum Reprod; 2017 Mar; 23(3):187-198. PubMed ID: 28158750
[TBL] [Abstract][Full Text] [Related]
33. The broad-spectrum chemokine inhibitor NR58-3.14.3 suppresses the implantation and survival of human endometrial implants in the nude mice endometriosis model.
Kayisli UA; Berkkanoglu M; Zhang L; Kizilay G; Arici A
Reprod Sci; 2007 Dec; 14(8):825-35. PubMed ID: 18089601
[TBL] [Abstract][Full Text] [Related]
34. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium.
Di Carlo C; Bonifacio M; Tommaselli GA; Bifulco G; Guerra G; Nappi C
Fertil Steril; 2009 Jun; 91(6):2315-23. PubMed ID: 18644593
[TBL] [Abstract][Full Text] [Related]
35. [Effects of cell growth and apoptosis of preneoplastic Syrian hamster embryo cells by green tea constituent epigallocatechin-3-gallate].
Jiao ZQ; Lü XZ; Guo YC; Kan B; Xu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Sep; 41(5):380-6. PubMed ID: 18206010
[TBL] [Abstract][Full Text] [Related]
36. Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.
Novella-Maestre E; Herraiz S; Vila-Vives JM; Carda C; Ruiz-Sauri A; Pellicer A
Fertil Steril; 2012 Nov; 98(5):1209-17. PubMed ID: 22921078
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
Chyu KY; Babbidge SM; Zhao X; Dandillaya R; Rietveld AG; Yano J; Dimayuga P; Cercek B; Shah PK
Circulation; 2004 May; 109(20):2448-53. PubMed ID: 15136500
[TBL] [Abstract][Full Text] [Related]
38. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice.
Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ
Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968
[TBL] [Abstract][Full Text] [Related]
39. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.
Machado DE; Berardo PT; Landgraf RG; Fernandes PD; Palmero C; Alves LM; Abrao MS; Nasciutti LE
Fertil Steril; 2010 May; 93(8):2674-9. PubMed ID: 20056215
[TBL] [Abstract][Full Text] [Related]
40. Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
Moon HS; Lee HG; Choi YJ; Kim TG; Cho CS
Chem Biol Interact; 2007 Apr; 167(2):85-98. PubMed ID: 17368440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
